Fidia Advances 2026 Convertible Bond Plan With New Share Issue

Fidia Spa ( (IT:FDA) ) has shared an announcement.

Fidia S.p.A., a Turin-based producer of high-performance numerical controls and integrated milling systems for the automotive mold and aerospace industries, remains one of the few industrial groups able to manage the full milling workflow, from machining programs to final output. The company markets and services its milling systems and CAM software worldwide, leveraging over half a century of specialized know-how.

Fidia has reported the conversion of three bonds from its reserved convertible bond loan with warrants, subscribed by Global Growth Holding Limited, into 4,285,713 new shares at a price of €0.007 per share. Following this partial execution of the related capital increase, Fidia’s share capital will rise by €30,000 to €11,357,761.90, bringing the total number of shares in issue to 113,745,306 and further advancing the subscription and conversion process of its 2026 financing plan.

More about Fidia Spa

Fidia S.p.A., headquartered in Turin and listed on Euronext Milan, is a global player in numerical control technology and high-performance integrated milling systems. With more than 50 years of experience and about 135 employees, it serves primarily the automotive mold and aerospace sectors, offering numerical controls, high-speed milling systems and CAM software that cover the entire milling process from programming to finished product.

Average Trading Volume: 3,168,417

Technical Sentiment Signal: Strong Sell

Current Market Cap: €572.2K

See more insights into FDA stock on TipRanks’ Stock Analysis page.